BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3922392)

  • 1. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
    MacMahon B; Bakshi M; Branagan P; Kelly JG; Walsh MJ
    Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocainide. A review of its pharmacological properties and therapeutic efficacy.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of concurrent administration of metoprolol and tocainide in acute myocardial infarction.
    Renard MB; Bernard RM; Ewalenko MB; Englert M
    J Cardiovasc Pharmacol; 1983; 5(1):116-20. PubMed ID: 6186845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemodynamic effects of intravenous tocainide in patients with heart disease.
    Winkle RA; Anderson JL; Peters F; Meffin PJ; Fowles RE; Harrison DC
    Circulation; 1978 Apr; 57(4):787-92. PubMed ID: 630689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effects of ajmaline and lidocaine on hemodynamics in myocardial infarct].
    Beck OA; Hochrein H
    Z Gesamte Inn Med; 1978 Jan; 33(1):5-10. PubMed ID: 622844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
    Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the kinetics and dynamics of tocainide and its metabolites.
    Ronfeld RA; Wolshin EM; Block AJ
    Clin Pharmacol Ther; 1982 Mar; 31(3):384-92. PubMed ID: 6800678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective effects of tocainide in canine acute myocardial infarction.
    Hiromasa S; Li ZY; Coto H; Maldonado C; Kupersmith J
    Int J Cardiol; 1990 Apr; 27(1):79-86. PubMed ID: 2110552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
    Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
    Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction.
    Nelson GI; Ahuja RC; Silke B; Okoli RC; Hussain M; Taylor SH
    Eur Heart J; 1983 Oct; 4(10):706-11. PubMed ID: 6653580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of intravenous frusemide in patients with myocardial infarction and left ventricular failure.
    Tattersfield AE; McNicol MW; Sillett RW
    Clin Sci Mol Med; 1974 Feb; 46(2):253-64. PubMed ID: 4817276
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.
    Wallace AA; Stupienski RF; Heaney LA; Gehret JR; Lynch JJ
    Am Heart J; 1991 May; 121(5):1413-21. PubMed ID: 1708198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic efficacy, pharmacokinetics and clinical safety of tocainide in convalescent myocardial infarction patients.
    Klein MD; Levine PA; Ryan TJ
    Chest; 1980 Jun; 77(6):726-30. PubMed ID: 6772381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of canrenoate potassium (aldactone pro injections) on hemodynamics and myocardial ischemia in experimental myocardial infarct].
    Kötter V; Leitner Ev; Arbeiter G; Cordes R; Schröder R
    Z Kardiol; 1975 Jul; 64(7):672-86. PubMed ID: 1163092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic dose-response effects of intravenous indoramin in acute heart failure complicating myocardial infarction.
    Silke B; Nelson GI; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S102-6. PubMed ID: 2423781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarction.
    Nyquist O; Forssell G; Nordlander R; Schenck-Gustafsson K
    Am Heart J; 1980 Dec; 100(6 Pt 2):1000-5. PubMed ID: 6778186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of intravenous morphine in patients with acute myocardial infarction complicated by severe left ventricular failure.
    Timmis AD; Rothman MT; Henderson MA; Geal PW; Chamberlain DA
    Br Med J; 1980 Apr; 280(6219):980-2. PubMed ID: 7417767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.